The others had type 1 OI, 21 with a dominant mutation in COL1A1, 5 with a dominant mutation in COL1A2, 5 without a genotype confirmation of COL1 mutation nor other genes in the panel, and one did not undergo genetic testing. This evidence concerns the gene COL1A1 and osteogenesis imperfecta type 1.